Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host
Junhua Wang, Nelson Marreros, Reto Rufener, Andrew Hemphill, Bruno Gottstein, Britta Lundström‐Stadelmann
Abstract
Alveolar echinococcosis (AE) is a deadly parasitic disease that requires lifelong treatment with albendazole. Development of host immunity is pivotal with regard to the clinical outcome of AE, but its influence on conventional albendazole treatment is unknown. Using T-cell deficient athymic nude mice, we demonstrated that functional immunity is required for albendazole to be efficacious against murine AE. These results call for attention given the increasing number of immunocompromised patients with AE.
Topics & Concepts
AlbendazoleEchinococcus multilocularisBiologyImmunityImmunologyEchinococcosisParasitic diseaseAlveolar echinococcosisCellular immunityEchinococcusHost (biology)ImmunocompetenceHelminthiasisDiseaseImmune systemPathologyMedicineEcologyZoologyParasitic infections in humans and animalsParasitic Infections and DiagnosticsParasite Biology and Host Interactions